Influence of the type of salt-forming acids on the antiradiation activity of T1023 analogs – salts of N-isobutanoyl-S-isopropylisothiourea

Author:

Filimonova M. V.1,Saburova A. S.1,Shevchenko L. I.1,Makarchuk V. M.1,Lychagin A. A.1,Filimonov A. S.1

Affiliation:

1. А. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation

Abstract

According to leading experts, the vast arsenal of radioprotective agents available in the world today does not fully meet modern practical needs, both in the field of radiation protection, and in the prevention and treatment of complications of radiotherapy. The purpose of the study was to evaluate the effect of the salt-forming acids type on the radioprotective activity of NOS inhibitor T1023. The chemical part of this study included methods of chemical synthesis, physicochemical and elemental analysis. Pharmacological part – assessment of acute toxicity using V.B. Prozorovsky express method and the study of radioprotective activity using Till and McCulloch method based on the ability of mice hematopoietic cells to form spleen colonies after irradiation. The number of endogenous hematopoietic spleen colonies were assessed on the 8th day after total exposure to gamma-irradiation at a dose of 6 Gy in six independent experiments. As a result of directed chemical synthesis, six new derivatives of T1023 – salts of N-isobutanoyl-S-isopropylisothiourea have been developed, identified and characterized. The results of studying the safety and radioprotective activity of the synthesized compounds showed that changes in the salt-forming acid don’t significantly influence the toxicity: all studied compounds are in the 3rd class of toxicity and hazard. At the same time, it was found that the replacement of the salt-forming acid significantly influenced the severity of the radioprotective effect. For some of these compounds radioprotective efficacy is comparable to or exceeds the efficacy of the initial compound T1023. It is important to note that these new compounds were used in lower, more save doses than T1023. The results suggest promising further development of NOS inhibitors – isothiourea derivatives as radioprotective agents.

Publisher

SPRI of Radiation Hygiene Prof. PV Ramzaev

Subject

Radiology Nuclear Medicine and imaging

Reference17 articles.

1. Grebenyuk AN, Gladkikh VD. Modern condition and prospects for the development of medicines towards prevention and early treatment of radiation damage. Biology bulletin. 2019;46(11): 1540-1555.

2. Rozhdestvensky LM. Challenges of development of radiation countermeasures. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2019;59(2): 117-126. (In Russian).

3. Singh VK, Newman VL, Romaine PL, Wise AY, Seed TM. Radiation countermeasure agents: an update (2011-2014). Expert Opinion on Therapeutic Patents. 2014;24(11): 1229-1255.

4. Singh VK, Seed TM, Olabisi AO. Drug discovery strategies for acute radiation syndrome. Expert Opinion on Drug Discovery. 2019;14(7): 701–715.

5. Rozhdestvensky LM. Actual problems of searching and studying radiation countermeasures. Radiatsionnaya biologiya. Radioekologiya = Radiation Biology. Radioecology. 2013;53(5): 513-520. (In Russian).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3